Press Releases

OVERVIEW
PRESS RELEASES
EVENTS
PRESENTATIONS
GOVERNANCE
STOCK INFO
FINANCIAL & FILINGS

Baudax Bio Announces Corporate Update

Oct 18, 2023 8:00am EDT

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

Sep 28, 2023 8:00am EDT

Email Alerts
Tear Sheet
RSS News Feed
Scroll to Top